ClinicalTrials.gg
RecruitingNCT07309510ALM-APUpdated Sep 16, 2026

Effectiveness of a Counseling Program on Exclusive Breastfeeding Rates in a Primary Care Center

An interventional study of breastfeeding counseling in Growth & Development, Breastfeeding Satisfaction and Breastfeeding Consultancy Training, sponsored by Fundación Pública Galega de Investigación Biomédica INIBIC. Recruiting at 1 site in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Fundación Pública Galega de Investigación Biomédica INIBIC · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 35 studies in Breast Feeding with a site in Spain — 6 open to participants now, 9 under way, none of them phase 3. Breast Feeding · Spain.

Planned enrollment
14th of 25
160 · median 200
Started
2026
with 3 others
No phase
20 of 35
2 open now
Registered
30th of 35
by date
Lead sponsor
1 of 35
Fundación Pública Galega de Investigación Biomédica INIBIC

Among the 35 studies in Breast Feeding with a site in Spain, this one is the 14th largest by planned enrollment of the 25 interventional ones, is one of 4 that started in 2026, is one of 20 with no phase, and was the 30th registered.

By phase

35 studies; the count open now beside each. This study's row is marked.

No phasethis study20 · 2 open
Observational10 · 3 open
Phase 42 · 0 open
Phase 1/21 · 1 open
Phase 2/31 · 0 open
Phase 31 · 0 open

By the year they started

First in 2002; this study’s year is marked. 4 started in 2026.

What they test

Size and results

Median enrollment 200 across the 25 interventional studies, 150 across the 10 observational. Of the 21 that completed or were terminated, 1 (5%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 35 studies in Breast Feeding with a site in Spain, or all of them as a file.
02

Study summary

Introduction: Evidence supports that exclusive breastfeeding (EBF) is the most beneficial method of infant feeding up to 6 months of age. The practice confers numerous advantages for the infant and the mother. Many breasfeeding are abandoned early due difficulties experienced after dischargue and after returning to work. Development specific early breastfeeding support programs in the community is necessary to avoid unwanted abandonment.

Objective: To analyse the differences in BF rates at six month of birth in healthy full-term newborns between the study groups.

Methodology: Pilot study of a randomised clinical trial carried out in a Paediatric Nursing clinic at the Ventorrillo Health Centre in A Coruña. The study population will be mothers of healthy full-term newborns who wish to give BF at the time of delivery and whose reference health centre is the one of the study. The mother- newborn dyads in the control group (CG) will receive the usual care described in the child health Program of the Galician Health Service, and the dyads included in the intervention group (IG) will also receive specific advice on breastfeeding during the first 6 months of life. A study sample of 80 participants is estimated for each group. The study will be approved by the Research Ethics Committee of A Coruña-Ferrol. The variables under study will be collected in a data collection notebook for later statistical analysis. A significant value of p \< 0.05 being considered.

03

Conditions studied

  • Growth & Development
  • Breastfeeding Satisfaction
  • Breastfeeding Consultancy Training
  • Breastfeeding Duration
  • Breastfeeding After Discharge From Hospital Following Childbirth, Yes/no
  • Breastfeeding, Exclusive
  • Breastfeeding Attitude
  • Breastfeeding Support System
  • Breastfeeding Rate
  • Breastfeeding Outcomes

Keywords

  • Breastfeeding
  • Infant
  • Human Milk
  • Health Education
  • Primary Health Care
  • Postpartum Period
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mothers who express a desire to breastfeed during a follow-up consultation with the Obstetric and Gynecological Nursing or Physician specialist at 36 weeks of gestation.
  • Mothers who plan to give birth at HMI of CHUAC, referred from the C.S. Ventorrillo.
  • Women who are fluent in Spanish or Galician.

Exclusion criteria

Exclusion Criteria:

  • Maternal age under 18 years - Maternal use of drugs or medication that prevent breastfeeding .
  • Maternal infection with or Human T-cell Leukemia Virus.
  • Mothers of newborns with cow's milk protein allergy, galactosemia, or congenital primary lactase deficiency.
  • Participate in other clinical trials.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
160 participants (estimated)

Study arms

  • No intervention
    Conventional care

    Conventional care within the Child Health Program (SERGAS) The health program includes 5 appointments with the Pediatric Specialist doctor and the Pediatric Specialist nurse in the first 6 months of life. These appointments will take place at 7-15 days, at 1 month, at 2 months, at 4 months, and at 6 months of age.

  • Experimental
    breastfeeding counseling

    Behavioral: breastfeeding counseling

Interventions

  • Behavioralbreastfeeding counseling

    The intervention group will receive, in addition to the indicated conventional care, 4 scheduled breastfeeding counseling appointments, the first of which will take place within the first 72 hours after hospital discharge following birth. As part of the breastfeeding counseling, the Latch scale will be used to observe and assess breastfeeding sessions, the breastfeeding self-efficacy scale-short (BSES-SF) to evaluate breastfeeding self-efficacy, the Visual Analogue Scale (VAS) to evaluate pain related to breastfeeding, and the breastfeeding clinical record form from the World Health Organization (WHO). Training will be provided to the mother and family on pre-selected breastfeeding topics. Mothers will be able to contact the IP nurse by phone daily on demand from 10 a.m. to 3 p.m.

06

What researchers measure

Primary outcomes

  1. Rate of exclusive breastfeeding at 6 months of age of the newborn

    The practice of feeding the infant exclusively with breast milk from 0 to 5 months (without giving any other food or drink, not even water). Nursing by a wet nurse, feeding with expressed breast milk, and feeding with breast milk from donors are also considered breastfeeding.

    Time frame: From birth up to 6 months of the infant's life

Secondary outcomes

  1. Number of participants with exclusive breastfeeding at 15 days, one month, and three months of the newborn's life.

    Defined as the practice of feeding the infant exclusively with breast milk (without giving any other food or drink, not even water). Breastfeeding by a wet nurse, feeding with expressed breast milk, and feeding with donor breast milk are also considered breastfeeding.

    Time frame: At 15 days, one month, and three months of the newborn's life.

  2. Number of participants with recovery to birth weight

    The infant regains the weight with which they were born

    Time frame: At 15 days and one month of age

  3. Grams of daily weight gain

    Grams of weight gained per day since the previous weight check.

    Time frame: At 15 days, 1 month, 2 months, 4 months and 6 months of the infant's life

  4. Age of introduction of complementary feeding

    Age of the infant at which complementary feeding is started in both study groups.

    Time frame: From birth to 6 months of age

  5. Number of Hospital admissions by the newborn

    Hospital admissions by the newborn in both study groups.

    Time frame: From birth to 6 months of age

  6. Number of emergency department visits by the newborn

    number and reason for emergency department visits by the newborn in both study groups.

    Time frame: From birth to 6 months of age

  7. Number of visits by the pediatric nurse specialist

    Number and reason for visits by the pediatric nurse specialist in both study groups.

    Time frame: Until completion of the study (6 months after birth)

  8. Number of visits to the specialist nurse in Obstetric-Gynecological Nursing

    Number of visits to the specialist nurse in Obstetric-Gynecological Nursing

    Time frame: Until completion of the study (6 months after birth)

  9. Days after birth of cessation of breastfeeding

    Days of the infant's life when the last breastfeeding is administered

    Time frame: Until completion of the study (6 months after birth)

  10. Score on the validated scale of impact of support networks in breastfeeding

    Score on the validated scale of impact of support networks in breastfeeding Validated scale of the impact of support networks on breastfeeding. Composed of 12 items, self-administered. Mothers must indicate their level of agreement or disagreement with the statements using a 5-point Likert scale. The maximum score is 60 points and the minimum is 12 points. A higher score indicates a greater degree of satisfaction or perceived quality among users of breastfeeding support services.

    Time frame: 6 months after birth or when the mother abandons the study

  11. Score of Maternal Breastfeeding Evaluation Scale (MBFES-E)

    Score on the Spanish version of the Maternal Breastfeeding Evaluation Scale (MBFES-E). A 5-point Likert-type scale is used in which the participant rates their level of agreement with the item statement (1: strongly disagree to 5: strongly agree). The final score on the scale will range from 30 to 150 and is interpreted such that a higher score indicates greater satisfaction with the breastfeeding experience.

    Time frame: 6 months after birth or when the mother abandons the study

07

Study locations

1 of 1 sites recruiting
  • Centro de Salud de O Ventorrillo
    A Coruña, Galicia, Spain
    Recruiting
    • Yolanda Sánchez Suárez · Contactyolanda.sanchez.suarez2@sergas.es · 981178000
    • Yolanda Sánchez Suárez · Principal investigator
    • Úrsula Nieto Caamaño · Sub investigator
    • Julia Varas Merino · Sub investigator
    • Tania Súarez Lavandeira · Sub investigator
    • María Tohux Pena · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Aug 2027, 18 months after the start.

Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 18 months is above that.

Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 19, 2025
First posted
Dec 30, 2025
StartActual
Feb 1, 2026
Primary completionEst.
Aug 2027
CompletionEst.
Jan 2028
Last update
Sep 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07309510
Lead sponsor
Fundación Pública Galega de Investigación Biomédica INIBIC
Responsible party
Yolanda Sánchez Suárez (Nurse specialist in Pediatric Nursing, Fundación Pública Galega de Investigación Biomédica INIBIC) — Principal investigator
First posted
Dec 30, 2025
Start date
Feb 1, 2026
Primary completion
Aug 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
Sep 16, 2026

Study contacts

Yolanda suarez Sánchez Suárez
Contact
yolanda.sanchez.suarez2@sergas.es
+34981142850
Carmen Neri Fernández Pombo, PhD
Contact
carmen.neri.fernandez.pombo@col.udc.es
Yolanda Sánchez Suárez
principal investigator · Servicio Gallego de Salud
Carmen Neri Fernández Pombo, PhD
principal investigator · Servicio Gallego de Salud. Instituto de Investigación Biomédica de A Coruña.
Javier Muñíz García, PhD
study director · Universidade de A Coruña

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion